Botulinum Toxin Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
EOLS | A | Evolus, Inc. | 2.63 | |
RVNC | C | Revance Therapeutics, Inc. | -1.69 | |
AEON | F | AEON Biopharma, Inc. | -4.15 | |
URGN | F | UroGen Pharma Ltd. | -0.49 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ARB | A | AltShares Merger Arbitrage ETF | 2.07 | |
MRGR | A | ProShares Merger ETF | 1.87 | |
IZRL | A | ARK Israel Innovative Technology ETF | 1.7 | |
PTH | D | Invesco DWA Healthcare Momentum ETF | 0.91 | |
XPH | B | SPDR S&P Pharmaceuticals ETF | 0.7 |
Compare ETFs
- Botulinum Toxin
Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Botulinum is the most acutely lethal toxin known, with an estimated human median lethal dose (LD50) of 1.3–2.1 ng/kg intravenously or intramuscularly and 10–13 ng/kg when inhaled.There are eight types of botulinum toxin, named type A–H. Types A and B are capable of causing disease in humans, and are also used commercially and medically. Types C–G are less common; types E and F can cause disease in humans, while the other types cause disease in other animals. Type H is considered the deadliest substance in the world – an injection of only 2 ng can cause death to an adult. Botulinum toxin types A and B are used in medicine to treat various muscle spasms and diseases characterized by overactive muscle. Commercial forms are marketed under the brand names Botox and Dysport, among others.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles